Arena Events Group
Arena Events Group plc is global turnkey event solutions provider, supplying temporary physical structures, seating, exhibition services, refrigeration, barriers & fencing, ice rinks, furniture, and interiors for some of the most prestigious events across the UK & Europe, the Americas, and the Middle East and Asia. Clients include Wimbledon Tennis, The Open, PGA European Tour, Ryder Cup, IMG, Google, and Frieze Art Fair.
Arena services major sporting, outdoor and leisure events, providing a managed solution from concept and design through to the construction and integration of the final structure and interior. Contracts range in size and complexity from a simple equipment rental for a local outdoor event, to an integrated solution of multiple structures and interiors for a major international sporting event.
CloudCall provide Unified Communications solutions that tightly integrate with CRM systems, allowing businesses to log all their communications including Voice, Text and Instant Messaging. By linking the customer data held in the CRM with communication software, businesses can use the critical insight and intelligence provided to make decisions faster and undertake more targeted and accurate interactions to increase productivity and drive business performance.
Creo Medical Group (CREO)
Creo Medical is a medical device company focused on the emerging field of surgical endoscopy, a recent development in minimally invasive surgery. The company’s mission is to improve patient outcomes by applying microwave and radiowave energy to surgical endoscopy.
Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.
Creo Medical listed on the AIM market of the London Stock Exchange on 9 December 2016, under the name “Creo Medical Group plc”.
Diaceutics is a data analytics and implementation service provider in diagnostic commercialization.
The company has been leading this field for 14 years, entirely focused on the intersection between diagnostics and therapeutic decision making. They provide an end to end service that encompasses everything from understanding the diagnostic landscape to test implementation into treatment pathways.
Diaceutics’ ultimate goal is to drive better testing to enable better treatment decisions for patients.
Duke Royalty (DUKE)
AIM-listed Duke Royalty is a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. The company, which is bringing royalty finance to UK and European businesses outside of the mining sector for the first time, has a market capitalisation of more than £120m and has one of the junior market’s highest yielding dividends.
FairFX Group (FFX)
FairFX is a leading challenger brand in banking and payments that provides banking and payment services to both personal and business customers through Current Accounts, Currency Cards, Travel Cash, International Money Transfers, and a Corporate Card and Expense Platform. FairFX has been helping customers get more since 2007 and continue to serve over 1 million customers.
Gresham House Strategic plc invests primarily in UK and European smaller public companies, applying private equity techniques and due diligence alongside a value investment philosophy to construct a focused portfolio expected to be comprised of 10-15 companies.
The Investment Manager aims for a considerably higher level of engagement with investee company stakeholders, including management, shareholders, customers, suppliers and competitors, with the aim of identifying market pricing inefficiencies and supporting a clear equity value creation plan and targeting above market returns over the longer-term.
Hardide is the leading global innovator and provider of advanced tungsten carbide coatings that significantly increase the working life of critical metal components operating in abrasive, erosive, corrosive and chemically aggressive environments. Our coatings are value-adding to components and lower operational costs by reducing downtime, increasing productivity and improving performance. They can be applied to external and internal surfaces including complex geometries, enabling a level of engineering design flexibility not possible with alternative technologies.
Immotion is focused on the delivery of truly immersive “out of home” Virtual Reality experiences through the combination of award winning VR content, and cutting-edge motion platform technology. It has three channels to market, each one solving a problem.
- Concession Partners – Delivering valuable ancillary revenue to high footfall leisure destinations. Partners include Merlin, Rank, Gravity Trampoline Parks to name but a few.
- Owned and franchised ImmoitonVR Experience Centres. – Bringing an entertainment destination to Shopping Malls.
- Sale of VR Motion Platforms – A range of operator-lite VR platforms, perfect for Family Entertainment Centres.
Inspiration Healthcare Group (IHC)
Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.
Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally, the Company has its own range of products for maintaining normothermia pre- during and post-surgery.
Intelligent Ultrasound Group (MED)
Intelligent Ultrasound (MED) develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity simulators for the ultrasound training market.
Based in the UK and US, the Group has raised over £25m to build an impressive portfolio of marketing leading products.
The Simulation Division focusses on hi-fidelity ultrasound training and has sold over 800 simulators to almost 500 medical institutions around the world.
Jaywing is a data science-led agency and consulting business, with a marketing technology division and growing international footprint. The agency has two core propositions, performance marketing and brand-led marketing. Jaywing’s data science consultancy helps clients do smart things with their data in marketing, credit risk, and business intelligence. Jaywing Intelligence offers AI and big data led products. Jaywing employs over 450 people, 15% of which are experienced data scientists, and has offices in Sheffield, Leeds, London, Newbury and Sydney.
Manolete Partners (MANO)
Manolete Partners Plc is the leading insolvency litigation financing company in the UK and was founded in 2009 by its CEO, Steven Cooklin. Manolete was listed on AIM in December 2018.
As at 30 September 2019, Manolete had invested in 344 UK insolvency litigation cases and completed 211 of them. Manolete is different from other litigation funders because cases are completed very quickly – the average case duration is less than 12 months. This is because Manolete owns, and is therefore in full control, of its cases. It is not a mere passive “funder” of cases. 96% of cases are settled long before trial - minimising costs and optimising returns.
Manolete won ‘Growth Company of the Year’ at the 2019 Shares Awards, which covers all listed UK companies. The Company is three-time winner of ‘Insolvency Litigation Funder of the Year’ at the Turnaround, Restructuring and Insolvency Industry Awards. Manolete was ranked 55 in the Financial Times’ list of ‘Europe’s Fastest Growing Companies’ in 2019.
Mercia Asset Management (MERC)
Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of balance sheet, venture, private equity and debt capital; the Group's 'Complete Capital Solution'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.
Mirada is a leading provider of products and services for Digital TV Operators and Broadcasters. Founded in 2000 and led by CEO José Luis Vázquez, the company prides itself on having spent almost 20 years as a pioneer in the Digital TV market. Mirada's core focus is on the ever-growing demand for TV Everywhere for which it offers a complete suite of end-to-end modular products across multiple devices, all with innovative state-of-the-art UI designs.
OPG Power Ventures (OPG)
OPG Power Ventures is principally engaged in the development, owning, operation, and maintenance of private sector power projects in India. The electricity generated from the company's plants is sold primarily to public sector undertakings and heavy industrial companies in India or in the short-term market. It operates through a single operating segment namely thermal power. The company generates all the revenue from the sale of electricity in India.
Radient Technologies is an extraction solutions provider and manufacturer of high-value natural ingredients and products. Our patented, proprietary MAP™ extraction platform safely extracts active natural compounds from a wide range of biological materials at rapid speed, providing superior customer outcomes in terms of ingredient purity, yield, and cost. Headquartered in Edmonton, Alberta, and fast becoming a global company, we work closely with our clients every step of the way to help them develop the highest quality naturally derived products. Radient is fully GMP compliant, Health Canada approved, and NNHPD certified.
Shield Therapeutics (STX)
Shield is a commercial stage, specialty pharmaceutical company delivering innovative pharmaceuticals to address patients' unmet medical needs. The Group’s lead product, Feraccru®/Accrufer® is approved for the treatment of iron deficiency in adults in the EU, USA and Switzerland. In Europe it is marketed as Feraccru® by Norgine and in the USA the product will be marketed as Accrufer®. Shield also has an exclusive licence agreement with Beijing Aosaikang Pharmaceutical Co. Ltd for the development and commercialisation of Feraccru®/Accrufer® in China.
Synnovia is a niche manufacturer of specialist products. Applications for these products vary widely and examples include:
• Packaging for the food manufacturing and distribution – films, sacks and pouches
• Steering columns and instrument control knobs in the automotive industry – plastic bearings
• Hydraulic and industrial rubber hose manufacture – various types of mandrel
• Cardboard box manufacture – creasing matrices
Synnovia’s business model is based on understanding customers’ problems in depth, and then developing and mass producing proprietary, technical solutions for these problems. As such many projects can take significant time to translate initial sale into volume production. The business operates through two divisions, Films and Industrial, and has the majority of its production in six UK based factories, with a further two factories in Asia and one in the USA. Approximately 50% of its £80 million sales, as per current run-rate, are made outside the UK to more than 80 countries.
Xpediator is the holding company for the Group, a well-established international provider of freight management services operating across the UK and Europe with a particular focus on, and expertise in, the CEE markets.
The Group currently employs over 600 people with its operational headquarters in Braintree, England, and country offices in Bulgaria, Lithuania, Estonia, Macedonia, Montenegro, Moldova, Romania and Serbia operating from 22 sites in total.